These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7735182)

  • 1. Ask the experts. Is suppression of lactation in postpartum patients still an indication for the use of bromocriptine mesylate (Parlodel)?
    Miller-Slade D
    AWHONN Voice; 1994 Nov; 2(11):11. PubMed ID: 7735182
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical commentary: the bromocriptine (Parlodel) controversy and recommendations for lactation suppression.
    Rayburn WF
    Am J Perinatol; 1996 Feb; 13(2):69-71. PubMed ID: 8672187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal myocardial infarction associated with bromocriptine for postpartum lactation suppression.
    Dutt S; Wong F; Spurway JH
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):116-7. PubMed ID: 9521411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.
    Herings RM; Stricker BH
    Pharm World Sci; 1995 Jul; 17(4):133-7. PubMed ID: 7581219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2-Br-alpha-ergocryptine (Parlodel) in primary and secondary lactation suppression following child-birth or abortion (author's transl)].
    Gehring H; Fischer S; Hofer U
    Schweiz Rundsch Med Prax; 1977 Aug; 66(31):985-9. PubMed ID: 556441
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
    Rolland R; Nijdam W; Weyer A; Lancranjan I
    Eur J Obstet Gynecol Reprod Biol; 1986 Sep; 22(5-6):337-43. PubMed ID: 3770284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of puerperal lactation: A comparative study of bromocriptine and pyridoxine.
    Boes EG
    S Afr Med J; 1980 May; 57(22):900-3. PubMed ID: 6996132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine to prevent lactation.
    Med Lett Drugs Ther; 1980 May; 22(11):48. PubMed ID: 6990220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of estradiol and parlodel in puerperal lactation inhibition].
    Myśkow M; Zalewski J
    Wiad Lek; 1980 Mar; 33(5):351-3. PubMed ID: 7376671
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of puerperal lactation by means of a single injection of bromocriptine retard.
    Valsamis J; Chavez H; Westelinck K; Haemers M; Francis G; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):43-51. PubMed ID: 3595974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Convulsions due to a postpartum cerebral angiopathy associated with the administration of bromocriptine].
    Burckard E; Patrigeon RG; Felten D; Combourieu E; Escarment J
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):46-9. PubMed ID: 12738020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central retinal vein occlusion in a woman receiving bromocriptine.
    Nagaki Y; Hayasaka S; Hiraki S; Yamada Y
    Ophthalmologica; 1997; 211(6):397-8. PubMed ID: 9380363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine (Parlodel) for suppression of lactation.
    Spalding G
    Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):344-5. PubMed ID: 1799348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of CB 154 (Parlodel) in the inhibition of milk production during the immediate post-partum period].
    Monnier JC; Boulogne M; Lanciaux B; Dognin C; Denuit MP
    Lille Med; 1977 Nov; 22(9 Suppl 2):739-42. PubMed ID: 609319
    [No Abstract]   [Full Text] [Related]  

  • 20. Changed indications for Parlodel (bromocriptine) for lactation suppression.
    Morgans D
    Med J Aust; 1995 Aug; 163(3):164. PubMed ID: 7643776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.